 | • レポートコード：MRC2-11QY04151 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は膵臓がん治療のグローバル市場について調査・分析したレポートです。種類別（生物学、化学療法、標的療法、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別膵臓がん治療の競争状況、市場シェア ・世界の膵臓がん治療市場：種類別市場規模 2015年-2020年（生物学、化学療法、標的療法、その他） ・世界の膵臓がん治療市場：種類別市場規模予測 2021年-2026年（生物学、化学療法、標的療法、その他） ・世界の膵臓がん治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の膵臓がん治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の膵臓がん治療市場分析：米国、カナダ ・ヨーロッパの膵臓がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの膵臓がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の膵臓がん治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの膵臓がん治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Roche、Pfizer、Merck、Celgene、Novartis、Amgen、Teva Pharmaceutical、PharmaCyte Biotech、Clovis Oncology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer.
In May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The drug is into phase III of the clinical trials. The acquisition will enhance the therapy products for the Eli Lilly and Company.
Market Analysis and Insights: Global Pancreatic Cancer Therapy Market
The global Pancreatic Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pancreatic Cancer Therapy Scope and Market Size
Pancreatic Cancer Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eli Lilly
Roche
Pfizer
Merck
Celgene
Novartis
Amgen
Teva Pharmaceutical
PharmaCyte Biotech
Clovis Oncology
Market segment by Type, the product can be split into
Biology
Chemotherapy
Targeted Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pancreatic Cancer Therapy Revenue
1.4 Market by Type
1.4.1 Global Pancreatic Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biology
1.4.3 Chemotherapy
1.4.4 Targeted Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Pancreatic Cancer Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Cancer Therapy Market Perspective (2015-2026)
2.2 Global Pancreatic Cancer Therapy Growth Trends by Regions
2.2.1 Pancreatic Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pancreatic Cancer Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Pancreatic Cancer Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pancreatic Cancer Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Pancreatic Cancer Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Therapy Players by Market Size
3.1.1 Global Top Pancreatic Cancer Therapy Players by Revenue (2015-2020)
3.1.2 Global Pancreatic Cancer Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Pancreatic Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pancreatic Cancer Therapy Market Concentration Ratio
3.2.1 Global Pancreatic Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Therapy Revenue in 2019
3.3 Pancreatic Cancer Therapy Key Players Head office and Area Served
3.4 Key Players Pancreatic Cancer Therapy Product Solution and Service
3.5 Date of Enter into Pancreatic Cancer Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pancreatic Cancer Therapy Historic Market Size by Type (2015-2020)
4.2 Global Pancreatic Cancer Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pancreatic Cancer Therapy Market Size by Application (2015-2020)
5.2 Global Pancreatic Cancer Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pancreatic Cancer Therapy Market Size (2015-2020)
6.2 Pancreatic Cancer Therapy Key Players in North America (2019-2020)
6.3 North America Pancreatic Cancer Therapy Market Size by Type (2015-2020)
6.4 North America Pancreatic Cancer Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pancreatic Cancer Therapy Market Size (2015-2020)
7.2 Pancreatic Cancer Therapy Key Players in Europe (2019-2020)
7.3 Europe Pancreatic Cancer Therapy Market Size by Type (2015-2020)
7.4 Europe Pancreatic Cancer Therapy Market Size by Application (2015-2020)
8 China
8.1 China Pancreatic Cancer Therapy Market Size (2015-2020)
8.2 Pancreatic Cancer Therapy Key Players in China (2019-2020)
8.3 China Pancreatic Cancer Therapy Market Size by Type (2015-2020)
8.4 China Pancreatic Cancer Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pancreatic Cancer Therapy Market Size (2015-2020)
9.2 Pancreatic Cancer Therapy Key Players in Japan (2019-2020)
9.3 Japan Pancreatic Cancer Therapy Market Size by Type (2015-2020)
9.4 Japan Pancreatic Cancer Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pancreatic Cancer Therapy Market Size (2015-2020)
10.2 Pancreatic Cancer Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pancreatic Cancer Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Pancreatic Cancer Therapy Market Size by Application (2015-2020)
11 India
11.1 India Pancreatic Cancer Therapy Market Size (2015-2020)
11.2 Pancreatic Cancer Therapy Key Players in India (2019-2020)
11.3 India Pancreatic Cancer Therapy Market Size by Type (2015-2020)
11.4 India Pancreatic Cancer Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pancreatic Cancer Therapy Market Size (2015-2020)
12.2 Pancreatic Cancer Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Pancreatic Cancer Therapy Market Size by Type (2015-2020)
12.4 Central & South America Pancreatic Cancer Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Pancreatic Cancer Therapy Introduction
13.1.4 Eli Lilly Revenue in Pancreatic Cancer Therapy Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Pancreatic Cancer Therapy Introduction
13.2.4 Roche Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Pancreatic Cancer Therapy Introduction
13.3.4 Pfizer Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Pancreatic Cancer Therapy Introduction
13.4.4 Merck Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview
13.5.3 Celgene Pancreatic Cancer Therapy Introduction
13.5.4 Celgene Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Pancreatic Cancer Therapy Introduction
13.6.4 Novartis Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Amgen
13.7.1 Amgen Company Details
13.7.2 Amgen Business Overview
13.7.3 Amgen Pancreatic Cancer Therapy Introduction
13.7.4 Amgen Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.7.5 Amgen Recent Development
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Details
13.8.2 Teva Pharmaceutical Business Overview
13.8.3 Teva Pharmaceutical Pancreatic Cancer Therapy Introduction
13.8.4 Teva Pharmaceutical Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.8.5 Teva Pharmaceutical Recent Development
13.9 PharmaCyte Biotech
13.9.1 PharmaCyte Biotech Company Details
13.9.2 PharmaCyte Biotech Business Overview
13.9.3 PharmaCyte Biotech Pancreatic Cancer Therapy Introduction
13.9.4 PharmaCyte Biotech Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.9.5 PharmaCyte Biotech Recent Development
13.10 Clovis Oncology
13.10.1 Clovis Oncology Company Details
13.10.2 Clovis Oncology Business Overview
13.10.3 Clovis Oncology Pancreatic Cancer Therapy Introduction
13.10.4 Clovis Oncology Revenue in Pancreatic Cancer Therapy Business (2015-2020)
13.10.5 Clovis Oncology Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pancreatic Cancer Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Pancreatic Cancer Therapy Revenue
Table 3. Ranking of Global Top Pancreatic Cancer Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pancreatic Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biology
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Targeted Therapy
Table 8. Key Players of Others
Table 9. Global Pancreatic Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Pancreatic Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Pancreatic Cancer Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Pancreatic Cancer Therapy Market Share by Regions (2015-2020)
Table 13. Global Pancreatic Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Pancreatic Cancer Therapy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Pancreatic Cancer Therapy Market Growth Strategy
Table 19. Main Points Interviewed from Key Pancreatic Cancer Therapy Players
Table 20. Global Pancreatic Cancer Therapy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Pancreatic Cancer Therapy Market Share by Players (2015-2020)
Table 22. Global Top Pancreatic Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Therapy as of 2019)
Table 23. Global Pancreatic Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Pancreatic Cancer Therapy Product Solution and Service
Table 26. Date of Enter into Pancreatic Cancer Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Pancreatic Cancer Therapy Market Size Share by Type (2015-2020)
Table 30. Global Pancreatic Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 31. Global Pancreatic Cancer Therapy Market Size Share by Application (2015-2020)
Table 32. Global Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Pancreatic Cancer Therapy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Pancreatic Cancer Therapy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Pancreatic Cancer Therapy Market Share (2019-2020)
Table 36. North America Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Pancreatic Cancer Therapy Market Share by Type (2015-2020)
Table 38. North America Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Pancreatic Cancer Therapy Market Share by Application (2015-2020)
Table 40. Europe Key Players Pancreatic Cancer Therapy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Pancreatic Cancer Therapy Market Share (2019-2020)
Table 42. Europe Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Pancreatic Cancer Therapy Market Share by Type (2015-2020)
Table 44. Europe Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Pancreatic Cancer Therapy Market Share by Application (2015-2020)
Table 46. China Key Players Pancreatic Cancer Therapy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Pancreatic Cancer Therapy Market Share (2019-2020)
Table 48. China Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 49. China Pancreatic Cancer Therapy Market Share by Type (2015-2020)
Table 50. China Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 51. China Pancreatic Cancer Therapy Market Share by Application (2015-2020)
Table 52. Japan Key Players Pancreatic Cancer Therapy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Pancreatic Cancer Therapy Market Share (2019-2020)
Table 54. Japan Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Pancreatic Cancer Therapy Market Share by Type (2015-2020)
Table 56. Japan Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Pancreatic Cancer Therapy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Pancreatic Cancer Therapy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Pancreatic Cancer Therapy Market Share (2019-2020)
Table 60. Southeast Asia Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Pancreatic Cancer Therapy Market Share by Type (2015-2020)
Table 62. Southeast Asia Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Pancreatic Cancer Therapy Market Share by Application (2015-2020)
Table 64. India Key Players Pancreatic Cancer Therapy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Pancreatic Cancer Therapy Market Share (2019-2020)
Table 66. India Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 67. India Pancreatic Cancer Therapy Market Share by Type (2015-2020)
Table 68. India Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 69. India Pancreatic Cancer Therapy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Pancreatic Cancer Therapy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Pancreatic Cancer Therapy Market Share (2019-2020)
Table 72. Central & South America Pancreatic Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Pancreatic Cancer Therapy Market Share by Type (2015-2020)
Table 74. Central & South America Pancreatic Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Pancreatic Cancer Therapy Market Share by Application (2015-2020)
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Product
Table 79. Eli Lilly Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 80. Eli Lilly Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Product
Table 89. Pfizer Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 90. Pfizer Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Product
Table 94. Merck Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 95. Merck Recent Development
Table 96. Celgene Company Details
Table 97. Celgene Business Overview
Table 98. Celgene Product
Table 99. Celgene Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 100. Celgene Recent Development
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Product
Table 104. Novartis Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 105. Novartis Recent Development
Table 106. Amgen Company Details
Table 107. Amgen Business Overview
Table 108. Amgen Product
Table 109. Amgen Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 110. Amgen Recent Development
Table 111. Teva Pharmaceutical Business Overview
Table 112. Teva Pharmaceutical Product
Table 113. Teva Pharmaceutical Company Details
Table 114. Teva Pharmaceutical Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 115. Teva Pharmaceutical Recent Development
Table 116. PharmaCyte Biotech Company Details
Table 117. PharmaCyte Biotech Business Overview
Table 118. PharmaCyte Biotech Product
Table 119. PharmaCyte Biotech Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 120. PharmaCyte Biotech Recent Development
Table 121. Clovis Oncology Company Details
Table 122. Clovis Oncology Business Overview
Table 123. Clovis Oncology Product
Table 124. Clovis Oncology Revenue in Pancreatic Cancer Therapy Business (2015-2020) (Million US$)
Table 125. Clovis Oncology Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Cancer Therapy Market Share by Type: 2020 VS 2026
Figure 2. Biology Features
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Others Features
Figure 6. Global Pancreatic Cancer Therapy Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Pancreatic Cancer Therapy Report Years Considered
Figure 11. Global Pancreatic Cancer Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pancreatic Cancer Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Pancreatic Cancer Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pancreatic Cancer Therapy Market Share by Players in 2019
Figure 16. Global Top Pancreatic Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Cancer Therapy Revenue in 2019
Figure 18. North America Pancreatic Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pancreatic Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pancreatic Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pancreatic Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pancreatic Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pancreatic Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pancreatic Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
膵臓がん治療薬の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …- 転移性膵臓がん治療の世界市場（～2026年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
- 膵臓がん診断の世界市場（～2026年） Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Bio…
- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…